New Therapy Helps People Rewire Their Brain to Manage Chronic Pain

New Therapy Helps People Rewire Their Brain to Manage Chronic Pain

Robert Howard
Robert Howard
2 Min.
A stone relief of a woman in a meditative lotus position, with long wavy hair, serene expression, and hands resting on her lap, set against a white background with text at the bottom.

New Therapy Helps People Rewire Their Brain to Manage Chronic Pain

A talk therapy programme called Pain Skills Coping Training (PCST) is helping people manage chronic pain without relying on medication. The approach focuses on teaching coping skills rather than eliminating pain completely. Recent studies show it can significantly reduce pain intensity and improve daily life for sufferers.

PCST combines relaxation techniques, mindfulness, meditation, and cognitive reframing to change how the brain processes pain. Research suggests chronic pain is often shaped more by the brain's response than by physical damage. The programme trains people to reframe symptoms and reduce their focus on pain signals.

Over the past five years, multiple studies have tested PCST's effectiveness. A 2023 trial at Stanford University, published in JAMA Network Open, found it cut pain intensity and interference in daily activities. In 2024, the University of Washington Pain Center confirmed similar results using skills based on Acceptance and Commitment Therapy (ACT). Meanwhile, the Karolinska Institutet in Sweden is running ongoing trials (2022–2025) to assess long-term benefits for fibromyalgia patients. A separate 2024 study also showed PCST helped dialysis patients manage chronic pain.

The author, who is neither a clinician nor investor in PCST, used the programme to cope with long-term back pain. By learning to shift attention away from pain signals, they found relief. An online version of the training is now available for those unable to attend in person.

PCST does not cure chronic pain but offers tools to lessen its impact on daily life. Those interested can find programmes through their GP or via an official online platform. The method continues to gain support from clinical trials and patient experiences.

Neueste Nachrichten